SPC
RETA

Slate Path Capital’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Slate Path Capital’s Portfolio RETA Stock Details RETA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-120,000
Closed -$24.5M – 32
2019
Q4 		$24.5M Hold
120,000
– – 1.32% 15
2019
Q3 		$9.64M Buy
+120,000
New +$9.64M 0.64% 15